SCHEMBL186629

SCHEMBL186629

N#CCC(=O)NC1CC1.O=C(O)NCc1ccc(Nc2ccc(Cl)cc2C(F)(F)F)cn1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.39
DRD3 P35462 1/20 0.39
DDR1 Q08345 1/20 0.37
CNR2 P34972 7/20 0.37
PTK2 Q05397 1/20 0.36
CNR1 P21554 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
RAB9A P51151 1/20 0.34
P2RX7 Q99572 2/20 0.34
LMNA P02545 1/20 0.34
GRIN2B Q13224 1/20 0.34
EPHX2 P34913 1/20 0.34
AR P10275 1/20 0.33
FLT3 P36888 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL185884 0.89 CNR2 (0.38) CNR2CNR1CYP1A2CYP2D6CYP2C19
SCHEMBL185747 0.88 CNR2 (0.39) CNR2CNR1CYP1A2CYP2D6CYP2C19
SCHEMBL185320 0.87 GAA (0.36) CNR2PTK2CNR1CYP1A2CYP2D6
SCHEMBL185393 0.84 CNR2 (0.42) CNR2CNR1CYP1A2CYP2D6CYP2C19
Trifluoroacetic Acid SCHEMBL14856625 0.82 CNR2 (0.40) CNR2CNR1CYP1A2CYP2D6CYP2C19
SCHEMBL2810189 0.81 CTSL (0.37) CNR2CYP1A2CYP2D6CYP2C19RAB9A
SCHEMBL185728 0.80 IRAK4 (0.39) CNR2CNR1
SCHEMBL2811071 0.77 RAB9A (0.44) HTR2ACNR2CYP1A2CYP2D6CYP2C19
SCHEMBL185476 0.75 KIT (0.40) CNR2CNR1P2RX7FLT3
SCHEMBL2809946 0.75 CNR2 (0.39) CNR2CYP1A2CYP2D6CYP2C19RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401256-B1 Compounds as bradykinin B1 antagonists BOEHRINGER INGELHEIM INT (DE) 2013-04-17 EP disclosed
EP-2401256-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-01-04 EP disclosed
WO-2010097372-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed